KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Humana (HUM) over the last 17 years, with Q3 2025 value amounting to $17.0 billion.

  • Humana's Non-Current Assets fell 66.74% to $17.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $67.3 billion, marking a year-over-year decrease of 283.7%. This contributed to the annual value of $4.0 billion for FY2024, which is 711.27% down from last year.
  • Per Humana's latest filing, its Non-Current Assets stood at $17.0 billion for Q3 2025, which was down 66.74% from $16.7 billion recorded in Q2 2025.
  • Humana's Non-Current Assets' 5-year high stood at $19.6 billion during Q2 2022, with a 5-year trough of $3.6 billion in Q4 2022.
  • Moreover, its 5-year median value for Non-Current Assets was $17.1 billion (2024), whereas its average is $15.0 billion.
  • In the last 5 years, Humana's Non-Current Assets surged by 30067.93% in 2021 and then tumbled by 8162.34% in 2022.
  • Over the past 5 years, Humana's Non-Current Assets (Quarter) stood at $19.5 billion in 2021, then plummeted by 81.62% to $3.6 billion in 2022, then rose by 19.09% to $4.3 billion in 2023, then fell by 7.11% to $4.0 billion in 2024, then soared by 328.78% to $17.0 billion in 2025.
  • Its Non-Current Assets stands at $17.0 billion for Q3 2025, versus $16.7 billion for Q2 2025 and $16.5 billion for Q1 2025.